Company Overview:
As the world's leader in the development and commercialization of therapeutic proteins, Novo Nordisk's balanced product portfolio not only includes the broadest insulin-based drug pipeline and most advanced delivery systems but, also, biopharmaceutical products for coagulation disorders, inflammation, autoimmune diseases, and growth hormone deficiencies.
Additional Company Information:
Novo Nordisk is both a partner and catalyst for change. We stand committed to making a significant difference in the lives of more than 13,000,000 patients worldwide, advancing the medical profession for the 21st century, and improving the health of our global society. Recognizing that global change requires looking beyond the corporate bench for solutions, Novo Nordisk seeks strategic partnerships with companies focused in its targeted therapy areas. We strive to conduct business in a financially, environmentally and socially responsible way, contribute to the enrichment of the communities in which we operate, and serve the cause we stand for.
Brand Names:
Levemir, NovoLog (NovoRapid in EU), NovoLog Mix 70/30 (NovoMix in EU), NovoSeven RT, Norditropin, PrandiMet, Activella, Vagifem
On-site Specials:
Request a meeting through myBIO prior to May 18th and be entered into a drawing for a sleek, new MacBook Pro. (Make sure to include your contact information.) And, while you're visiting, bring your room key to Booth #2521 and see what it may unlock for you…an iPod Touch…a Nintendo Wii...or Small Wonder video cameras. We’ll see you at booth #2521…and don’t forget your key. Novo Nordisk...unlocking the promise of biotechnology.
This Exhibitor offers products & services in the following categories:
• Biotechnology and Related Specialties
» Biotechnology Company
» Drug Delivery
» Drug Discovery
» Proteomics
» Therapeutics